AI Verdict
LUCN has stronger fundamentals based on our AI analysis.
LUCN vs LTRN Fundamental Comparison
| Metric | LUCN | LTRN |
|---|---|---|
| Revenue | $0.0 | N/A |
| Net Income | $-22,173.0 | $-17.1M |
| Net Margin | N/A | N/A |
| ROE | N/A | -262.0% |
| ROA | N/A | -155.1% |
| Current Ratio | 0.00x | 2.40x |
| Debt/Equity | N/A | 0.00x |
| EPS | N/A | $-1.57 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LUCN vs LTRN: Frequently Asked Questions
Is LUCN or LTRN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LUCN has stronger fundamentals. LUCN is rated STRONG SELL (98% confidence) while LTRN is rated STRONG SELL (87% confidence). This is not investment advice.
How does LUCN compare to LTRN fundamentally?
Lucent, Inc. has ROE of N/A vs Lantern Pharma Inc.'s -262.0%. Net margins are N/A vs N/A respectively.
Which stock pays higher dividends, LUCN or LTRN?
LUCN has a dividend yield of N/A or no dividend while LTRN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LUCN or LTRN for long term?
For long-term investing, consider that LUCN has STRONG SELL rating with 98% confidence, while LTRN has STRONG SELL rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LUCN vs LTRN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LUCN vs LTRN, the AI consensus favors LUCN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.